These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33327999)

  • 21. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Instructive Role of MLL-Fusion Proteins Revealed by a Model of t(4;11) Pro-B Acute Lymphoblastic Leukemia.
    Lin S; Luo RT; Ptasinska A; Kerry J; Assi SA; Wunderlich M; Imamura T; Kaberlein JJ; Rayes A; Althoff MJ; Anastasi J; O'Brien MM; Meetei AR; Milne TA; Bonifer C; Mulloy JC; Thirman MJ
    Cancer Cell; 2016 Nov; 30(5):737-749. PubMed ID: 27846391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application and prognostic relevance of CD34 detection in immunophenotyping of pediatric acute B lymphoblastic leukemia.
    Zha W; Yuan Y; Yang T; Zhu LJ; Kong WY; Zhuo JJ
    Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3384-3390. PubMed ID: 38766795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
    Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
    Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical characteristics of children with B cell type acute lymphoblastic leukemia carrying different fusion gene].
    Zuo YX; Zhang LP; Lu AD; Wang B; Liu GL
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Mar; 12(3):172-6. PubMed ID: 20350423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification.
    De Zen L; Bicciato S; te Kronnie G; Basso G
    Leukemia; 2003 Aug; 17(8):1557-65. PubMed ID: 12886243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The Best Time of Minimal Residual Disease Monitoring for Predicting Survival and Prognosis in Children with T-Cell Acute Lymphoblastic Leukemia].
    Bao H; Li TY; Wu YT; Xiao ZT; Zhang L; Luo LY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1471-1477. PubMed ID: 34627426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic factors of pediatric patients with Ph-positive acute lymphoblastic leukemia].
    Xue YJ; Wu J; Zuo YX; Jia YP; Lu AD; Zhang LP
    Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):219-224. PubMed ID: 29562467
    [No Abstract]   [Full Text] [Related]  

  • 29. MLL-rearranged mixed phenotype acute leukemia masquerading as B-cell ALL.
    Yang W; Tran P; Khan Z; Rezk S; O'Brien S
    Leuk Lymphoma; 2017 Jun; 58(6):1498-1501. PubMed ID: 27774846
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognostic Significance of Mixed-Lineage Leukemia (MLL) Gene Detected by Real-Time Fluorescence Quantitative PCR Assay in Acute Myeloid Leukemia.
    Huang S; Yang H; Li Y; Feng C; Gao L; Chen GF; Gao HH; Huang Z; Li YH; Yu L
    Med Sci Monit; 2016 Aug; 22():3009-17. PubMed ID: 27561414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
    Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
    Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of cross-lineage expression of the myeloid-associated antigens CD13 and CD33 in adult B-lymphoblastic leukemia: A large real-world study of 1005 patients.
    Liao H; Lai H; Chen J; Shuai X; Zhang X; Yang Y; Lyu M; Zheng Q
    Cancer Med; 2023 Apr; 12(8):9615-9626. PubMed ID: 36951610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of immunophenotypic markers in pediatric T-cell acute lymphoblastic leukemia.
    Sidhom I; Shaaban K; Soliman S; Ezzat S; El-Anwar W; Hamdy N; Yassin D; Salem S; Hassanein H; Mansour MT
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):111-20. PubMed ID: 20029466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The Factors Affecting Relapse in Pediatric B-cell Acute Lymphoblastic Leukemia Patients without Prognostic Fusion Genes Following Up for 10 years].
    Jiang MY; Gao W; Gao J; Ling J; Pan J; Xiao PF; Lu J; He HL; Wang Y; Li J; Li JQ; Chai YH; Sun YN; Hu SY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):12-17. PubMed ID: 35123597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Favorable outcome in non-infant children with MLL-AF4-positive acute lymphoblastic leukemia: a report from the Tokyo Children's Cancer Study Group.
    Tomizawa D; Kato M; Takahashi H; Fujimura J; Inukai T; Fukushima T; Kiyokawa N; Koh K; Manabe A; Ohara A
    Int J Hematol; 2015 Nov; 102(5):602-10. PubMed ID: 26410102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.
    Hilden JM; Dinndorf PA; Meerbaum SO; Sather H; Villaluna D; Heerema NA; McGlennen R; Smith FO; Woods WG; Salzer WL; Johnstone HS; Dreyer Z; Reaman GH;
    Blood; 2006 Jul; 108(2):441-51. PubMed ID: 16556894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996.
    Piciocchi A; Messina M; Elia L; Vitale A; Soddu S; Testi AM; Chiaretti S; Mancini M; Albano F; Spadano A; Krampera M; Bonifacio M; Cairoli R; Vetro C; Colella F; Ferrara F; Cimino G; Bassan R; Fazi P; Vignetti M
    Am J Hematol; 2021 Sep; 96(9):E334-E338. PubMed ID: 34048072
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical significance of minimal residual disease in B-lineage acute lymphoblastic leukemia pediatric patients with different fusion gene backgrounds].
    Wei T; Chen XJ; Zhang LY; Zhang AL; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Dec; 22(12):1279-1285. PubMed ID: 33327998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunophenotypic shift in the B-cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B-lymphoblastic leukemia.
    Chatterjee G; Sriram H; Ghogale S; Deshpande N; Khanka T; Panda D; Pradhan SN; Girase K; Narula G; Dhamane C; Malik NR; Banavali S; Patkar NV; Gujral S; Subramanian PG; Tembhare PR
    Cytometry B Clin Cytom; 2021 Jul; 100(4):434-445. PubMed ID: 32896101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.